These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 23472801)
21. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone. Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269 [TBL] [Abstract][Full Text] [Related]
22. Update on Emerging Infections: news from the Centers for Disease Control and Prevention. Update to the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections . Maldonado NG; Takhar SS Ann Emerg Med; 2013 Jan; 61(1):91-5. PubMed ID: 23260686 [No Abstract] [Full Text] [Related]
23. Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial. Rob F; Klubalová B; Nyčová E; Hercogová J; Unemo M Clin Microbiol Infect; 2020 Feb; 26(2):207-212. PubMed ID: 31419483 [TBL] [Abstract][Full Text] [Related]
24. Partner Therapy in Sexually Transmitted Infections: A Teachable Moment. Keshvani N; Nijhawan A; Gupta A JAMA Intern Med; 2018 Aug; 178(8):1108-1109. PubMed ID: 29889926 [No Abstract] [Full Text] [Related]
26. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Unemo M; Golparian D; Hestner A Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645 [TBL] [Abstract][Full Text] [Related]
27. Practice alert: CDC no longer recommends quinolones for treatment of gonorrhea. Campos-Outcalt D J Fam Pract; 2007 Jul; 56(7):554-8. PubMed ID: 17605948 [No Abstract] [Full Text] [Related]
28. Azithromycin in the treatment of infection with Neisseria gonorrhoeae. Bignell C; Garley J Sex Transm Infect; 2010 Nov; 86(6):422-6. PubMed ID: 20940153 [TBL] [Abstract][Full Text] [Related]
29. ECDC public health response to the threat of resistant gonorrhoea in Europe. Van de Laar M Euro Surveill; 2012 Jun; 17(24):. PubMed ID: 22720771 [No Abstract] [Full Text] [Related]
30. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011. Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301 [TBL] [Abstract][Full Text] [Related]
31. Antibiotic susceptibility of Neisseria gonorrhoeae in Arkhangelsk, Russia. Vorobieva V; Firsova N; Ababkova T; Leniv I; Haldorsen BC; Unemo M; Skogen V Sex Transm Infect; 2007 Apr; 83(2):133-5. PubMed ID: 16971401 [TBL] [Abstract][Full Text] [Related]
32. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Unemo M; Golparian D; Potočnik M; Jeverica S Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003 [TBL] [Abstract][Full Text] [Related]
33. Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines. Farhi D; Hotz C; Poupet H; Gerhardt P; Morand P; Poyart C; Sednaoui P; Avril MF; Dupin N Acta Derm Venereol; 2009; 89(5):484-7. PubMed ID: 19734973 [TBL] [Abstract][Full Text] [Related]
34. Can the clinical efficacy of different antibiotic dosage regimens in gonorrhoea be predicted from the gonocidal effect of the corresponding plasma level profiles simulated in vitro? Korting HC; Ollert M; Lukacs A; Schäfer-Korting M Acta Derm Venereol; 1987; 67(2):154-9. PubMed ID: 2438881 [TBL] [Abstract][Full Text] [Related]
35. Emergence and spread of drug resistant Neisseria gonorrhoeae. Deguchi T; Nakane K; Yasuda M; Maeda S J Urol; 2010 Sep; 184(3):851-8; quiz 1235. PubMed ID: 20643433 [TBL] [Abstract][Full Text] [Related]
37. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634 [TBL] [Abstract][Full Text] [Related]
38. What is the appropriate therapy for asymptomatic gonorrhoea in men who have sex with men? Kenyon CR; Osbak K; Vandenbruane M Int J STD AIDS; 2016 Aug; 27(9):812-3. PubMed ID: 27485832 [No Abstract] [Full Text] [Related]
39. [Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics]. Koedijk FD; van den Broek I; Stirbu-Wagner I; van Bergen JE Ned Tijdschr Geneeskd; 2013; 157(24):A5642. PubMed ID: 23759175 [TBL] [Abstract][Full Text] [Related]
40. 'Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea' - Author's reply. Rob F; Unemo M Clin Microbiol Infect; 2020 Jun; 26(6):799-800. PubMed ID: 32120033 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]